Status:
UNKNOWN
Analgesic Efficacy of the Erector Spinae Plane Block Using Bupivacaine Versus Bupivacaine/Magnesium Sulphate in Patients Undergoing Lumbar Spine Surgery
Lead Sponsor:
Beni-Suef University
Conditions:
Postoperative Pain
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Introduction: Severe postoperative pain following spine surgery is a significant cause of morbidity, extended length of facility stay, and marked opioid usage The analgesic regime for postoperative ...
Detailed Description
The aim of this study is to evaluate the efficacy of the Erector Spinae Plane Block using bupivacaine versus bupivacaine/magnesium sulphate in Patients Undergoing Lumbar Spine surgery Inclusion crite...
Eligibility Criteria
Inclusion
- orthopedic
- neurological patients
- undergoing posterior lumbar spine fusion
- American Society of Anesthesiologists (ASA) physical status 1 or 2.
Exclusion
- Contraindications for regional blocks
- allergic reaction to drugs.
- Patients with a history of liver, renal, heart and vascular failure, cardiac conduction disturbance.
- opium addiction, any drug or substance abuse and chronic treatment with opium, non-steroidal anti-inflammatory drugs and calcium channel blockers (CCB).
Key Trial Info
Start Date :
July 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 10 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04433624
Start Date
July 18 2020
End Date
December 10 2020
Last Update
July 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Banī Suwayf, Egypt, 11391
Banī Suwayf, Egypt